Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Emerging Antibiotics: Will We Have What We Need?
Link ID 22173
Title Emerging Antibiotics: Will We Have What We Need?
Url http://www.medscape.com/viewarticle/715971?src=rss
Description Patients are already dying of untreatable bacterial infections. We must take action now to avert a more serious healthcare crisis. Medscape Infectious Diseases
Category Articles > Allergy and Clinical Immunology
Keywords
Date Feb 4, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. Tdap Vaccine Protects Against Pertussis During Outbreak
  The Tdap vaccine (a tetanus, reduced-dose diphtheria, and acellular pertussis booster) effectively protected adolescents during a pertussis outbreak in the US Virgin Islands in 2007. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


2. Skin Tests May Give Clues to Safe Iodinated Contrast MediaSkin Tests May Give Clues to Safe Iodinate
  For patients with delayed allergic reactions to iodinated contrast media (ICM), skin tests may help in selecting an alternative agent, French researchers suggest. br / iReuters Health Information/i
Category:   Articles > Allergy and Clinical Immunology


3. Blue-Jean Button Nickel: Prevalence and Prevention of Its Release From Buttons
  Nickel is a common cause of allergic contact dermatitis and is associated with metal buttons and snaps on blue jeans. One solution is to coat the button with clear nail polish.
Dermatitis
Category:   Articles > Allergy and Clinical Immunology


4. The Effect of Dose and Timing of Dose on the Association Between Airborne Particles and Survival
  Could reduction in airborne particle concentrations increase life expectancy?
Environmental Health Perspectives
Category:   Articles > Allergy and Clinical Immunology


5. New FDA Recommendations for Discontinuation of Long-Acting Beta Agonists Run Counter to Asthma Manag
  Long-acting beta agonists should be discontinued once asthma symptoms are stabilized, according to new US Food and Drug Administration recommendations. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS